Germans Trias i Pujol Health Sciences Research Institute (IGTP)

Germans Trias i Pujol Health Sciences Research Institute (IGTP)

Research Institute

Spain · Badalona | PROFESSIONAL

About Germans Trias i Pujol Health Sciences Research Institute (IGTP)

1 followers

MISSIONS

The mission of the Health Sciences Research Institute of the “Germans Trias i Pujol” Foundation (IGTP) are to generate, preserve, disseminate and increase multidisciplinary and translational knowledge, as well as echnological development in biomedical sciences, by means of a dynamic, efficient and effective organisation.



GOALS

The ultimate goal of the IGTP is to become a research centre of reference, able to transfer the generated knowledge into clinical practice and therapeutics (translationality), in order to optimise the psychophysical health and quality of life of the population.



VISION

- The IGTP, as an institution devoted to biomedical research:

- Assumes its humanitarian view, ethical principles, and solidarity, as well as the principles of sustainability in resource management and relationship with the environment.

- Its activities will be always related with the health needs of the population and the priority areas in healthcare development.

- Assumes the scientific method as its own and faces its goals by means of programs of excellence which enable the leadership in the areas of knowledge of the interest of its researchers.

- Protects the data used in, and generated by the research programmes, as well as the privacy of the patients and healthy individuals who participate in them.
Research areas
Diagnostics, DiagnosisHeart and blood circulation illnessesNeurology, Brain ResearchBiology / BiotechnologyGenome Research and 3 more
Organization Website
Organization Type
Research Institute
Founded
Headquarters
Germans Trias i Pujol Health Sciences Research Institute (IGTP)

Portfolio of Technology Offers (6)

Our group has demonstrated that intravenous administration of apotransferrin strongly reduces the brain damage (up to 75%) in 3 different rat models including both transient and permanent ischemic stroke and improves the neurological impairment (neuroscore 60%) induced by stroke. Thus, this new appr[…]

The invention is based on a previous strategy of the group, consisting on a cell immunotherapy based on autologous dendritic cells (DCs) loaded with apoptotic β-cells for the treatment of autoimmunity in experimental T1D. To overcome the difficulties of sourcing apoptotic β-cells, a synthetic therap[…]

The device presented enables the combination of both electrical and mechanical stimulation either independently or simultaneously. The mechanical stimulation is performed with a non-invasive and aseptic novel approach. A sterile, single use device is placed into a standard culture plate. The cel[…]

The present data provide a solid basis for the development of genetic biomarkers for the early identification of patients suffering from dementia with Lewy bodies and to classify them into specific molecular subtypes. One of the biomarkers correlates with the development of Lewy pathology in the bra[…]

New developed hydrogel dressing shield, biocompatible, biodegradable and bioactive, with an appropriate viscosity and adhesion capacity, easy to apply with the endoscope, to treat mucosal lesions in the gastrointestinal tract.[…]

Currently, the glucocorticoids are the first-line of treatment for of moderate-to-severe flare-ups. However, up to 40% of patients do not have an adequate response. Mechanisms of steroid-refractoriness in UC remains unknown. In addition, corticosteroid failure impair the effectiveness of rescue th[…]

Start collaborating Now!

We are currently seeking best-in-class collaboration partners for the postings listed below. You can respond to current opportunities by browsing the listed entries. We do want to invite you to cooperate with us so please contact us through the available template and we will get in contact with you. Please provide as much detailed information as possible in order to facilitate the engagement process.

Contact Person

Maria  Ortega

Maria Ortega

Innovation Manager at Germans Trias i Pujol Health Sciences Research Institute (IGTP)

View Profile

Share this site